Hydrix Limited (ASX:HYD) has raised capital via a placement
Hydrix Limited has completed a capital raise with institutional and sophisticated investors. The capital will be used to bolster the company’s growth strategy and to extinguish outstanding secured debt.
Hydrix is a product innovation company providing product development services for clients in large addressable global markets, including medical and industrial, and connected cardiovascular technologies and services throughout the Asia Pacific region. With over 200 successfully designed products and solutions, Hydrix is recognized as one of the leading product development companies in Australia. It has three core business segments: services, medical and ventures. The company is underpinned by world-class product development expertise within Hydris Services and is now leveraging these skill sets to create and capture the value that it creates for its customers via Hydrix Medical and Hydrix Ventures.
Oaklins’ team in Australia acted as co-manager in this transaction.
Talk to the deal team
Managing DirectorMelbourne, Australia
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.Learn more
Biosynex has acquired Para’kito
Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.Learn more